Melanotan II: The Questions You Should Ask Before You Ever Open a Vial

Start with the obvious one. Melanotan II is not an FDA-approved drug. It is sold, almost entirely, as a “research chemical,” by vendors who ask nothing about your health history and owe you nothing after the sale clears. What exists instead of a safety record is a scattered stack of case reports, doctors and toxicologists writing up what happened when real people used it and something went wrong. That is the material this piece works from. Below, the side effects are laid out as a sequence of questions, because that is really how most people encounter this compound: one worried search at a time.

What happens to almost everyone who uses it?

Two things, reliably: nausea and flushing. The first human pilot study of Melanotan II recorded nausea and facial flushing as the most common effects, not a fluke reaction in a few unlucky subjects but the typical response (Dorr et al., 1996, Life Sciences). A later placebo-controlled trial, the one that confirmed the drug does produce erections, found the same pattern: nausea and yawning were frequent, and at higher doses a meaningful share of subjects had severe nausea (Wessells et al., 2000, International Journal of Impotence Research).

That detail about dose matters more than it sounds. Push the dose to tan faster, and the nausea rises with it. There is no clever workaround, because the tan and the sickness come from the same mechanism.

Two more effects belong on this list, lower stakes but worth naming honestly. Existing moles and freckles commonly darken, and new dark spots can appear, which is the drug’s pigment effect doing exactly what it is designed to do, in places you might not want it. Spontaneous yawning and stretching also turn up in the research, an odd companion to the nausea, but a documented one.

Why do all these different symptoms show up together?

Because they trace back to one shared switch. Melanotan II activates melanocortin receptors, and those receptors sit in more than one tissue. In the skin, they drive melanocytes to make melanin, hence the tan, and the darkened moles. In the vascular system, they touch blood pressure and heart rate. In the genital tissue, the same receptor activity that produces “increased libido” can also produce an erection that will not stop. One receptor, several downstream effects, some wanted and some not. Nobody selling the compound organizes the risk information this way, but it is the throughline connecting nearly every item on this page.

What can go wrong without you feeling it?

Blood pressure. This is the one that concerns clinicians more than users, precisely because there is often no symptom attached. Melanotan II can shift blood pressure and heart rate through its action on the melanocortin system, and a person injecting a research-chemical powder at home has no built-in way to notice that happening. A blood pressure cuff is inexpensive and the check takes a minute. The problem is that nobody in the gray-market supply chain is asking anyone to use one.

Does it raise the risk of skin cancer?

This is the question that deserves the most weight, because it is not settled and it is not small. Melanotan II works by driving melanocytes, and melanocytes are the same cells involved in melanoma, the most dangerous form of skin cancer. A case report describes a 20-year-old woman with fair skin who developed melanoma after a course of Melanotan II self-injections, used to deepen a sunbed tan; the authors urged clinicians to counsel at-risk patients about the drug’s hazards (Hjuler and Lorentzen, 2014, Dermatology). A 2017 review raised the same concern more broadly, flagging changes in existing moles and the theoretical melanoma link, alongside a general warning about the dangers of these unregulated products (Habbema et al., 2017, International Journal of Dermatology).

The practical takeaway: anyone using this compound is widely advised to have their moles examined by a clinician and to flag any spot that changes shape, border, or color. A vial delivered in a padded envelope cannot look at your skin. Only a person can do that.

What are the actual emergency-room cases?

Two, both documented, both uncommon, both real.

Priapism is a painful erection that will not go down, and it is a urological emergency; left untreated, it can cause lasting tissue damage and permanent erectile dysfunction. Men have been treated for exactly this after Melanotan II use, in a case report bluntly titled “a hard-earned tan” (Dreyer et al., 2019, BMJ Case Reports). It is the same erectile mechanism that gives the drug its libido reputation, just running past the point anyone wanted.

Rhabdomyolysis is a dangerous breakdown of muscle tissue, one that can injure the kidneys. A man developed systemic toxicity and rhabdomyolysis after injecting Melanotan II (Nelson et al., 2012, Clinical Toxicology).

Neither of these is the typical experience. But rare is not the same as impossible, and both cases put someone in a hospital bed.

What’s actually in the vial?

Possibly not what the label claims. Research-chemical vendors operate with no pharmacy oversight, no verified concentration, and no accountability if the product is underdosed, degraded, or contaminated. The 2017 review named this directly, warning about the dangers of buying and injecting an unlicensed product of unknown quality (Habbema et al., 2017), and a 2009 BMJ editorial made the same point years earlier, describing these products as unlicensed substances sold to the public over the internet (Evans-Brown et al., 2009, BMJ).

So the purity question sits on top of every other risk already listed. Even someone who has weighed the nausea, the blood pressure question, and the mole question is still taking a second, separate gamble on what the vial actually contains.

So what does a safer approach look like?

Not “never touch it,” because that is not a realistic instruction and it is not what harm reduction is built on. The realistic version starts from the fact that some people will use this compound regardless, and asks what would make that less dangerous.

The clearest answer is: do not do it alone. The risks that matter most here, the blood pressure shift you cannot feel and the mole change you might not notice, are exactly the ones that need a trained person watching for them. That is the entire argument for a supervised route over a mail-order vial. FormBlends runs a physician-supervised setup that fits that description: a clinician reviews your history before anything starts, can ask about your moles, can check your blood pressure, can tell you plainly when the right answer is not to use the drug at all, and dispenses through a licensed pharmacy rather than an anonymous seller.

None of that makes Melanotan II safe. Nothing currently does, on the evidence that exists. Compounded medications are prepared by licensed pharmacies for an individual patient and remain unapproved by the FDA. What supervision buys is screening beforehand, a verified product instead of a mystery powder, and a real person to call if something goes wrong, which matters a great deal for a compound with a documented emergency-room history.

So, is it worth it?

That is a personal call, but it should be an informed one. Nausea and flushing are close to guaranteed, and worsen with dose. Blood pressure can shift without warning signs. The same pigment cells the drug stimulates are implicated in melanoma, and a melanoma has already been reported in a user. Rare but real cases have ended in priapism and rhabdomyolysis, both requiring emergency treatment. And on the gray market, there is no guarantee the vial contains what it claims. Anyone weighing a cosmetic tan against that list deserves to see the whole list, not the trimmed version a product page offers.

Questions I hear again and again

What is the most common side effect of Melanotan II?

Nausea and facial flushing, and both should be expected rather than hoped against. They were the typical experience in the earliest human study of the compound [1], and the placebo-controlled erection trial found nausea frequent as well, with severe nausea in a meaningful share of subjects at higher doses [2]. The redness and the queasiness share a mechanism with the tan itself, so there is no dosing strategy that keeps one and drops the other.

Does Melanotan II increase your risk of skin cancer?

The concern is real and unresolved, which is why it deserves attention rather than dismissal. The compound drives melanocytes, the same pigment cells implicated in melanoma, and a melanoma has been reported in a young woman who used Melanotan II to deepen a sunbed tan [3]. A dermatology review separately raised concern about changes in existing moles and the theoretical melanoma link [6]. Anyone using it is widely advised to have a clinician monitor their moles, something no mail-order vial can do.

Can Melanotan II cause a medical emergency?

Yes, in a small number of documented cases. Priapism, a painful erection that will not subside and can cause permanent damage, has sent men to emergency rooms after use [5]. One man developed systemic toxicity and rhabdomyolysis, a dangerous breakdown of muscle tissue that can injure the kidneys [4]. These outcomes are uncommon, not typical, but they are documented, which means the worst-case scenario is not hypothetical.

Is Melanotan II FDA-approved or legal to buy?

No. It is not FDA-approved and is sold almost entirely as an unlicensed “research chemical” rather than as medicine. A 2009 BMJ editorial described these products as unlicensed substances marketed directly to the public over the internet [7], and the 2017 review warned specifically about buying and injecting an unlicensed product of unknown quality [6]. That gray-market status adds a separate risk on top of the drug’s own known effects.

How do you reduce the risks of Melanotan II?

The single most protective step is not doing it alone. The risks that matter most, the blood pressure shifts you cannot feel and the mole changes you might miss, are precisely the ones that need a trained observer. A supervised route means pre-use screening, a verified product instead of a mystery powder, and someone to call if something goes wrong. Supervision does not make the compound safe, since nothing currently does, but it removes the parts of the risk you have no other way to manage.

Why do sellers not list these side effects?

Because their job stops at the checkout, and a full accounting of the risks works against that job. The published record on this compound is mostly case reports of things going wrong, not a body of reassuring safety data, and that context rarely makes it onto a sales page. Laying out the documented risks plainly is the opposite of what a seller is incentivized to do.

Does melanotan II change eye color?

There is no reliable evidence that it changes eye color in humans. What is documented, including in case reports, is darkening of existing moles and freckles, along with new pigmented spots. A few users describe changes in iris appearance, but this has not been studied in any controlled way. Unexpected pigment change in the eyes warrants a prompt visit to an ophthalmologist, not a dose adjustment.

Does melanotan II work without sun exposure?

It produces some melanin stimulation on its own, but most users see a much deeper tan when they add UV exposure. The peptide triggers melanocytes to produce and distribute melanin, and sunlight then oxidizes that melanin into a darker shade. The danger is treating the resulting tan as sun protection: the actual SPF benefit of a melanotan-induced tan is minimal and has not been well studied.

How much melanotan II should I take?

There is no established safe human dose, because the compound has never completed clinical trials for tanning use. Figures circulating on forums, typically 0.25 mg to 1 mg per injection, come from user communities, not medical research. Dose-dependent effects, including severe nausea, blood pressure changes, and priapism, are documented even at the lower end of that range. In a legitimate, physician-supervised channel such as FormBlends, dosing would be set by a clinician, not copied from a forum thread.

Where do people actually buy melanotan II, and what are the risks of those sources?

Mostly through gray-market websites, research-chemical vendors, and gym networks, none of which are held to pharmaceutical manufacturing standards. Independent testing of products from these channels has repeatedly turned up incorrect concentrations, bacterial contamination, and unlisted additives. There is no way to verify what is actually in the vial you are injecting, which compounds every other risk described above, since the substance itself carries no guarantee and no medical oversight is watching for a reaction.

References (primary sources)

1. Dorr RT, Lines R, Levine N, Brooks C, Xiang L, Hruby VJ, et al. Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study. Life Sciences, 1996. PMID 8637402.
2. Wessells H, Levine N, Hadley ME, Dorr R, Hruby V. Melanocortin receptor agonists, penile erection, and sexual motivation: human studies with Melanotan II. International Journal of Impotence Research, 2000. PMID 11035391.
3. Hjuler KF, Lorentzen HF. Melanoma associated with the use of melanotan-II. Dermatology, 2014. PMID 24355990.
4. Nelson ME, Bryant SM, Aks SE. Melanotan II injection resulting in systemic toxicity and rhabdomyolysis. Clinical Toxicology, 2012. PMID 23121206.
5. Dreyer BA, Amer T, Fraser M. Melanotan-induced priapism: a hard-earned tan. BMJ Case Reports, 2019. PMID 30796078.
6. Habbema L, Halk AB, Neumann M, Bergman W. Risks of unregulated use of alpha-melanocyte-stimulating hormone analogues: a review. International Journal of Dermatology, 2017. PMID 28266027.
7. Evans-Brown M, Dawson RT, Chandler M, McVeigh J. Use of melanotan I and II in the general population. BMJ, 2009. PMID 19224885.